These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8649300)

  • 21. Markers for transfusion-associated hepatitis in north Indian blood donors: prevalence and trends.
    Singh B; Verma M; Verma K
    Jpn J Infect Dis; 2004 Apr; 57(2):49-51. PubMed ID: 15118208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Seroprevalence of hepatitis B and C and of human immunodeficiency virus among blood donors in south-west Nigeria.
    Mabayoje VO; Oparinde DP; Akanni EO; Taiwo SS; Muhibi MA; Adebayo TO
    Br J Biomed Sci; 2007; 64(4):177-9. PubMed ID: 18236741
    [No Abstract]   [Full Text] [Related]  

  • 23. [Hepatitis following transfusion].
    Fürst G; Kostuch B; Peichl-Hoffmann G; Kellner S
    Beitr Infusionsther; 1988; 21():187-91. PubMed ID: 2462974
    [No Abstract]   [Full Text] [Related]  

  • 24. [A retrospective examination of a hepatitis focus in plasma donors].
    Golosova TV; Osechinskiĭ IV; Somova AV; Valeev IA; Gusarova VP; Shevchenko TV
    Gematol Transfuziol; 1993 Feb; 38(2):42-4. PubMed ID: 8020723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety of blood supply in the Caribbean countries: role of screening blood donors for markers of hepatitis B and C viruses.
    Cruz JR; Pérez-Rosales MD; Zicker F; Schmunis GA
    J Clin Virol; 2005 Dec; 34 Suppl 2():S75-80. PubMed ID: 16461244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effectiveness of donor selection for reducing the risk of HCV, HBV and HIV in new blood donors.
    Whyte GS; Savoia HF
    Med J Aust; 1997 Jun; 166(11):611. PubMed ID: 9201185
    [No Abstract]   [Full Text] [Related]  

  • 27. Donor transaminase and recipient hepatitis. Impact on blood transfusion services.
    Alter HJ; Purcell RH; Holland PV; Alling DW; Koziol DE
    JAMA; 1981 Aug; 246(6):630-4. PubMed ID: 6788964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Risk of infection in hemotherapy].
    Sibrowski W; Wüllenweber J
    Infusionsther Transfusionsmed; 1994 Aug; 21 Suppl 1():60-3. PubMed ID: 8000255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. U.S. Public Health Service inter-agency guidelines for screening donors of blood, plasma, organs, tissues, and semen for evidence of hepatitis B and hepatitis C.
    Can Dis Wkly Rep; 1991 Nov; 17(46):251-7; discussion 257-8. PubMed ID: 1843654
    [No Abstract]   [Full Text] [Related]  

  • 30. Risk of transfusion-transmitted infections by NAT-negative blood.
    Koehler M; Riggert J; Legler T; Mayr WR; Schwartz DW; Heermann KH
    Transfusion; 2003 Jun; 43(6):830-1; author reply 830. PubMed ID: 12757539
    [No Abstract]   [Full Text] [Related]  

  • 31. Infectious disease complications of GI endoscopy: part II, exogenous infections.
    Nelson DB
    Gastrointest Endosc; 2003 May; 57(6):695-711. PubMed ID: 12709700
    [No Abstract]   [Full Text] [Related]  

  • 32. Residual transfusion risk for hepatitis B and C in southern Brazil, 1991-99.
    Kupek EJ
    J Viral Hepat; 2001 Jan; 8(1):78-82. PubMed ID: 11155155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relative safety of first-time volunteer and replacement donors in West Africa.
    Allain JP; Sarkodie F; Asenso-Mensah K; Owusu-Ofori S
    Transfusion; 2010 Feb; 50(2):340-3. PubMed ID: 19843284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decrease in reported posttransfusion hepatitis. Contributions of donor screening for alanine aminotransferase and antibodies to hepatitis B core antigen and changes in the general population.
    Chambers LA; Popovsky MA
    Arch Intern Med; 1991 Dec; 151(12):2445-8. PubMed ID: 1747001
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ASGE guideline for infection control during GI endoscopy.
    ; Calderwood AH; Day LW; Muthusamy VR; Collins J; Hambrick RD; Brock AS; Guda NM; Buscaglia JM; Petersen BT; Buttar NS; Khanna LG; Kushnir VM; Repaka A; Villa NA; Eisen GM
    Gastrointest Endosc; 2018 May; 87(5):1167-1179. PubMed ID: 29573782
    [No Abstract]   [Full Text] [Related]  

  • 36. Incident hepatitis among repeat blood donors: A sentinel event signaling possible health care-associated infection and need for reporting to public health authorities.
    Moorman AC; Stramer SL; Schaefer MK; Collier MG; Suryaprasad A; Kuehnert MJ; Moore Z; Rowan E; Habicht K; Bradley K; Fucci MC; Hopkins C; Xu F
    Transfusion; 2015 Oct; 55(10):2531-3. PubMed ID: 25899171
    [No Abstract]   [Full Text] [Related]  

  • 37. [Present status of infectious diseases transmitted by blood transfusion and the preventive measures].
    Shimoyama T
    Masui; 1999; 48 Suppl():S33-40. PubMed ID: 10785958
    [No Abstract]   [Full Text] [Related]  

  • 38. Donor levels of serum alanine aminotransferase activity and antibody to hepatitis B core antigen associated with recipient hepatitis C and non-B, non-C outcomes.
    Mosley JW; Huang W; Stram DO; Nowicki MJ; Hollinger FB; Aach RD; Stevens CE; Barbosa LH; Nemo GJ
    Transfusion; 1996 Sep; 36(9):776-81. PubMed ID: 8823449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Significant increase in HBV, HCV, HIV and syphilis infections among blood donors in West Bengal, Eastern India 2004-2005: exploratory screening reveals high frequency of occult HBV infection.
    Bhattacharya P; Chandra PK; Datta S; Banerjee A; Chakraborty S; Rajendran K; Basu SK; Bhattacharya SK; Chakravarty R
    World J Gastroenterol; 2007 Jul; 13(27):3730-3. PubMed ID: 17659734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of posttransfusion hepatitis B and C by screening for antibody to hepatitis C virus and antibody to HBcAg.
    Chung HT; Lee JS; Lok AS
    Hepatology; 1993 Nov; 18(5):1045-9. PubMed ID: 7693569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.